232 related articles for article (PubMed ID: 23899662)
1. Epigenetic modifications in breast cancer and their role in personalized medicine.
Stefansson OA; Esteller M
Am J Pathol; 2013 Oct; 183(4):1052-1063. PubMed ID: 23899662
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic changes in BRCA1-mutated familial breast cancer.
Downs B; Wang SM
Cancer Genet; 2015 May; 208(5):237-40. PubMed ID: 25800897
[TBL] [Abstract][Full Text] [Related]
3. Epigenetics of breast cancer: Biology and clinical implication in the era of precision medicine.
Pasculli B; Barbano R; Parrella P
Semin Cancer Biol; 2018 Aug; 51():22-35. PubMed ID: 29339244
[TBL] [Abstract][Full Text] [Related]
4. Epigenetics in breast and prostate cancer.
Wu Y; Sarkissyan M; Vadgama JV
Methods Mol Biol; 2015; 1238():425-66. PubMed ID: 25421674
[TBL] [Abstract][Full Text] [Related]
5. Epigenomics, Pharmacoepigenomics, and Personalized Medicine in Cervical Cancer.
Kabekkodu SP; Chakrabarty S; Ghosh S; Brand A; Satyamoorthy K
Public Health Genomics; 2017; 20(2):100-115. PubMed ID: 28521327
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment.
Dworkin AM; Huang TH; Toland AE
Semin Cancer Biol; 2009 Jun; 19(3):165-71. PubMed ID: 19429480
[TBL] [Abstract][Full Text] [Related]
7. Epigenetics in Personalized Management of Lung Cancer.
Ahmad A
Adv Exp Med Biol; 2016; 890():111-22. PubMed ID: 26703801
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer.
Yamashita N; Tokunaga E; Kitao H; Hitchins M; Inoue Y; Tanaka K; Hisamatsu Y; Taketani K; Akiyoshi S; Okada S; Oda Y; Saeki H; Oki E; Maehara Y
Clin Breast Cancer; 2015 Dec; 15(6):498-504. PubMed ID: 26195437
[TBL] [Abstract][Full Text] [Related]
9. Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women's cancers.
Jones A; Lechner M; Fourkala EO; Kristeleit R; Widschwendter M
Epigenomics; 2010 Feb; 2(1):9-38. PubMed ID: 22122746
[TBL] [Abstract][Full Text] [Related]
10. The Epigenomic Revolution in Breast Cancer: From Single-Gene to Genome-Wide Next-Generation Approaches.
Davalos V; Martinez-Cardus A; Esteller M
Am J Pathol; 2017 Oct; 187(10):2163-2174. PubMed ID: 28734945
[TBL] [Abstract][Full Text] [Related]
11. Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes.
Messier TL; Gordon JA; Boyd JR; Tye CE; Browne G; Stein JL; Lian JB; Stein GS
Oncotarget; 2016 Feb; 7(5):5094-109. PubMed ID: 26783963
[TBL] [Abstract][Full Text] [Related]
12. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation as a promising landscape: A simple blood test for breast cancer prediction.
Khakpour G; Pooladi A; Izadi P; Noruzinia M; Tavakkoly Bazzaz J
Tumour Biol; 2015 Jul; 36(7):4905-12. PubMed ID: 26076810
[TBL] [Abstract][Full Text] [Related]
14. Impact of hyperhomocysteinemia on breast cancer initiation and progression: epigenetic perspective.
Naushad SM; Reddy CA; Kumaraswami K; Divyya S; Kotamraju S; Gottumukkala SR; Digumarti RR; Kutala VK
Cell Biochem Biophys; 2014 Mar; 68(2):397-406. PubMed ID: 23934182
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic inactivation of DNA repair in breast cancer.
Nowsheen S; Aziz K; Tran PT; Gorgoulis VG; Yang ES; Georgakilas AG
Cancer Lett; 2014 Jan; 342(2):213-22. PubMed ID: 22634493
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic mechanisms of breast cancer: an update of the current knowledge.
Karsli-Ceppioglu S; Dagdemir A; Judes G; Ngollo M; Penault-Llorca F; Pajon A; Bignon YJ; Bernard-Gallon D
Epigenomics; 2014; 6(6):651-64. PubMed ID: 25531258
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic Biomarkers for Environmental Exposures and Personalized Breast Cancer Prevention.
Park HL
Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32069786
[TBL] [Abstract][Full Text] [Related]
18. Exploring breast carcinogenesis through integrative genomics and epigenomics analyses.
Minning C; Mokhtar NM; Abdullah N; Muhammad R; Emran NA; Ali SA; Harun R; Jamal R
Int J Oncol; 2014 Nov; 45(5):1959-68. PubMed ID: 25175708
[TBL] [Abstract][Full Text] [Related]
19. Comparative epigenetic analyses reveal distinct patterns of oncogenic pathways activation in breast cancer subtypes.
Li Y; Li S; Chen J; Shao T; Jiang C; Wang Y; Chen H; Xu J; Li X
Hum Mol Genet; 2014 Oct; 23(20):5378-93. PubMed ID: 24871326
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer susceptibility testing: past, present and future.
Goldberg JI; Borgen PI
Expert Rev Anticancer Ther; 2006 Aug; 6(8):1205-14. PubMed ID: 16925486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
